Cam on CaMKII and heart failure research

At the DGK Annual Meeting 2023, Prof. Donald M. Bers, University of California, Davis, reports on his research on the pleitropic enzyme CaMKII, which is involved in various pathological processes in the body. He also talks about possible therapeutic approaches and other research topics he is working on.

Von: Romy Martínez

26.07.2023


Video interview: Heart failure research

with Prof. Donald M. Bers, University of California, Davis, School of Medicine, USA

Related Links

Prof. Mark Anderson, University of Chicago Medical Center, about his research on inhibitors of the protein kinase CaMKII and transatlantic research collaborations.

Link to the online portal of the 89th Annual Meeting

Here you will find the videos of the DGK Annual Meeting 2023.
Access is restricted to DGK members and conference attendees. You don't have a DGK membership yet? Learn more about the benefits of being a DGK member.

Das könnte Sie auch interessieren

Neue Erkenntnisse zur DAPT-Dauer bei ACS

ESC 2025 | DUAL ACS/TARGET FIRST/NEOMINDSET: 3 Studien liefern neue Hinweise für eine DAPT-Dauer nach ACS von 1 Monat. Von PD Dr. L. Gaede.

Dr R. Wijesurendra about the AMALFI study

ESC 2025 | AMALFI: Dr R. Wijesurendra about Active Monitoring for Atrial Fibrillation.

Prof. M. Abdel-Wahab zur DOUBLE-CHOICE-Studie

ESC 2025 | DOUBLE-CHOICE: Prof. M. Abdel-Wahab zu Anästhesiestrategien und selbstexpandierende Klappen für TAVI.

Laden, bitte warten.
Diese Seite teilen